114
6
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T40196 | PI3Kγ inhibitor 5 | ||
PI3Kγ inhibitor 5 is a potent inhibitor of phosphoinositide 3-kinase γ (PI3Kγ), exhibiting an exceptional IC50 value of 34 nM. | |||
T12465 | PI3Kγ inhibitor 2 | PI3K | |
PI3Kγ inhibitor 2 is an orally bioavailable inhibitor of PI3Kγ(Ki of 4 nM). | |||
T12464 | PI3Kγ inhibitor 1 | PI3K | |
PI3Kγ inhibitor 1 is a inhibitor of PI3Kδ and PI3Kγ. | |||
T72613 | PI3Kγ inhibitor 6 | ||
PI3Kγ Inhibitor 6, a specific inhibitor of PI3Kγ, is utilized in the study of inflammatory and autoimmune diseases. | |||
T79111 | PI3Kγ inhibitor 7 | PI3K | |
PI3Kγ Inhibitor 7 (compound 2) is a potent, orally active agent that selectively inhibits PI3Kγ with an IC50 of 3.42 nM and demonstrates antitumor activity [1]. It also exhibits varying inhibitory effects on other PI3K i... | |||
T62165 | PI3Kγ inhibitor 4 | ||
PI3Kγ inhibitor 4 is a selective, potent, orally active PI3Kγ inhibitor (IC50: 40 nM). PI3Kγ inhibitor 4 is ~7-fold more selective for PI3Kγ than the α subtype, 43-fold more selective than the β subtype and 18-fold more ... | |||
T14214 | AMG 511 | PI3K | |
AMG 511 is a potent and orally available pan inhibitor of class I PI3Ks(Kis of 4 nM, 6 nM, 2 nM and 1 nM for PI3Kα, β, δ and γ, respectively). It exhibits anti-tumor activity in mouse glioblastoma xenograft model[1]. AMG... | |||
T7879 | TASP0415914 | Akt , PI3K | |
TASP0415914 is an orally potent inhibitor of phosphoinositide 3-kinase γ (PI3Kγ). T | |||
T21938 | AS-041164 | PI3K | |
AS-041164 is a selective and orally active PI3Kγ isoform inhibitor(IC50 of 70 nM), and shows less activity against PI3Kα, PI3Kβ, and PI3Kδ (IC50s of 240 nM, 1.45 μM, and 1.70 μM, respectively). It has anti-inflammatory e... | |||
T6704 | TG 100713 | TG100713 | PI3K |
TG 100713 is a pan-PI3K inhibitor against PI3Kγ, PI3Kδ, PI3Kα and PI3Kβ with IC50 of 50 nM, 24 nM, 165 nM and 215 nM, respectively. | |||
T22339 | GNE-490 | Others , PI3K | |
GNE-490 is an effective inhibitor of pan-PI3K with IC50s of 3.5 nM, 25 nM, 5.2 nM, 15 nM for PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ, respectively. GNE-490 has >200 fold selectivity for mTOR (IC50 = 750 nM). | |||
T6208 | AS-252424 | Casein Kinase , PI3K | |
AS-252424 is a potent and selective inhibitor of PI3Kγ with IC50 of 33 nM; >10 fold selectivity for PI3Kγ versus PI3Kα. | |||
T2672 | TG100-115 | PI3K | |
TG100-115 is a PI3Kγ/δ inhibitor (IC50: 83/235 nM), with fewer effects on PI3Kα/β. | |||
T6394 | AS-604850 | PI3K | |
AS-604850 is a specific and ATP-competitive PI3Kγ inhibitor (IC50: 250 nM), 18-fold more selective for PI3Kγ than PI3Kα, and over 80-fold selectivity for PI3Kγ than PI3Kδ/β. | |||
T2248 | AS-605240 | AS 605240 | PI3K , Autophagy |
AS-605240 is an effective and specific inhibitor of PI3Kγ (IC50/Ki: 87.8 nM). | |||
T6433 | CAY10505 | Apoptosis , PI3K | |
CAY10505, a form of dehydroxyl of AS-252424, is a PI3Kγ inhibitor (IC50: 33 nM). | |||
T6799 | IITZ-01 | Apoptosis , PI3K , Autophagy | |
IITZ-01 is potent autophagy inhibitor with single-agent anticancer activity ( IC50 of 2.62 μM for PI3Kγ.) | |||
T5432 | Eganelisib | IPI-549 | PI3K |
Eganelisib (IPI-549) is an inhibitor of PI3Kγ (IC50 = 16, 3,200, 3,500, and >8,400 nM for PI3Kγ, PI3Kα, PI3Kβ, and PI3Kδ, respectively) | |||
T7166 | GNE-493 | PI3K , mTOR | |
GNE-493 is potent, selective, and orally available PI3K and mTOR inhibitor with potential anticancer activity.IC50s of 3.4 nM, 12 nM, 16 nM, 16 nM and 32 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR,respectively. | |||
T13119 | Tenalisib | RP6530 | PI3K |
Tenalisib (RP6530) (RP6530) is a potent and selective inhibitor of PI3Kδ and PI3Kγ(IC50 values of 25 and 33 nM, respectively.) | |||
T64392 | PI3K-IN-46 | PI3K | |
PI3K-IN-46 is a specific inhibitor of PI3Kγ. | |||
T6731 | WYE-354 | Apoptosis , PI3K , mTOR , Autophagy | |
WYE-354(IC50=5 nM) is an effective, selective and ATP-competitive mTOR inhibitor. It blocks mTORC2/P-AKT(S473) and mTORC1/P-S6K(T389), not P-AKT(T308). The selectivity for mTOR is higher than PI3Kα (>100-fold) and PI3Kγ ... | |||
T12459 | PI3K/mTOR Inhibitor-2 | PI3K , mTOR | |
T6557 | KU-0060648 | KU0060648 | DNA-PK , PI3K , mTOR |
KU-0060648 is a dual inhibitor of DNA-PK and PI3Kα, PI3Kβ, PI3Kδ with IC50 of 8.6 nM and 4 nM, 0.5 nM, 0.1 nM respectively, less inhibition of PI3Kγ with IC50 of 0.59 μM. | |||
T6732 | WYE-687 | p38 MAPK , PI3K , Src , mTOR | |
WYE-687 is an ATP-competitive and selective inhibitor of mTOR with IC50 of 7 nM; blocks mTORC1/pS6K(T389) and mTORC2/P-AKT(S473) but no effect observed on P-AKT(T308). Selectivity for mTOR is greater than PI3Kα (>100-fol... | |||
T1949 | CZC24832 | PI3K | |
CZC24832 is a selective inhibitor of PI 3-kinase γ. | |||
T3656 | PKI-402 | PI3K , mTOR | |
PKI-402 is a potent PI3K and mTOR inhibitor. PKI-402 inhibits PI3Kα, mTOR, PI3Kβ, PI3Kδ and PI3Kγ with IC50s of 2, 3, 7, 14 and 16 nM, respectively. | |||
T3986 | SF2523 | DNA-PK , Epigenetic Reader Domain , PI3K , mTOR | |
SF2523 is a highly selective and potent inhibitor. | |||
T36200 | AZD 3147 | mTOR | |
AZD 3147 is an inhibitor of mTORC with IC50s of 40.7 and 5.75 nM for mTORC1 and mTORC2. AZD 3147 shows IC50s of 912, 5495, 9333, and 6310 nM for PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ, respectively. | |||
T12469 | PI4KIIIbeta-IN-9 | PI3K , PI4K | |
PI4KIIIbeta-IN-9 is a potent inhibitor of PI4KIIIβ(IC50 of 7 nM). . | |||
T6072 | BGT226 maleate | BGT226,NVP-BGT226 (maleate),NVP-BGT226 | Apoptosis , PI3K , mTOR , Autophagy |
BGT226 maleate (NVP-BGT226) is a class I PI3K/mTOR inhibitor for PI3Kα/β/γ (IC50: 4/63/38 nM) . | |||
T1916 | Apitolisib | RG 7422,GNE 390,GDC-0980 | Apoptosis , PI3K , mTOR |
Apitolisib (RG 7422), an effective, class I PI3K inhibitor for PI3Kα(IC50=5 nM), PI3Kβ(IC50=27 nM), PI3Kδ(IC50=7 nM), PI3Kγ (IC50=14 nM), is used in trials study of solid cancers, breast cancer, prostate cancer, renal ce... | |||
T14998 | Copanlisib dihydrochloride | BAY 80-6946 dihydrochloride | Apoptosis , PI3K , mTOR |
Copanlisib dihydrochloride (BAY 80-6946 dihydrochloride) is an ATP-competitive pan-class I PI3K inhibitor (IC50s: 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI3Kδ, PI3Kβ and PI3Kγ). Copanlisib dihydrochloride has super... | |||
T1970 | Gedatolisib | PF-05212384,PKI-587 | PI3K , mTOR |
Gedatolisib (PF-05212384) is a highly effective dual inhibitor targeting the PI3Kα/γ (IC50: 0.4/5.4 nM)and mTOR (IC50: 1.6 nM) in the PI3K/mTOR signaling pathway. | |||
T36083 | DS-7423 | PI3K , mTOR | |
DS-7423 is a dual PI3K and mTOR inhibitor, with IC50 values of 15.6 nM, 34.9 nM for PI3Kα and mTOR, respectively. DS-7423 possesses anti-tumor activity[1][2]. DS-7423 increases TP53 expression, the level of p-TP53 on Ser... | |||
T6730 | WAY-600 | WAY600 | VEGFR , PI3K , Src , mTOR |
WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); selective for mTOR than PI3Kα (>100-fold) and PI3Kγ (>500-fold... | |||
T6103 | VS-5584 | SB2343,VS 5584,VS5584 | PI3K , mTOR |
VS-5584 (SB2343) is a pan-PI3K/mTOR kinase inhibitor. | |||
T1999 | Taselisib | RG-7604,GDC-0032 | PI3K , Carbonic Anhydrase |
Taselisib (GDC-0032) is an orally bioavailable inhibitor of the class I phosphatidylinositol 3-kinase (PI3K) alpha isoform (PIK3CA), with potential antineoplastic activity. | |||
T6168 | ZSTK474 | PI3K , Autophagy | |
PI3K Inhibitor ZSTK474 is an orally available, s-triazine derivative, ATP-competitive phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. | |||
T6319 | OSI-027 | ASP4786,OSI027 | DNA-PK , PI3K , mTOR , Autophagy |
OSI-027 (ASP4786) is a selective and potent dual inhibitor of mTORC1 and mTORC2 with IC50 of 22 nM and 65 nM, and more than 100-fold selectivity observed for mTOR than PI3Kα, PI3Kβ, PI3Kγ or DNA-PK. Phase 1. | |||
T6072L | BGT226 | BGT226 free base,NVP-BGT226 | PI3K , mTOR , Autophagy |
BGT226 (NVP-BGT226) is a novel dual PI3K / mTOR inhibitor, it acts on PI3K α/β/γ with IC50 of 4 nM / 63 nM / 38 nM, respectively. | |||
T6773 | AZD8186 | PI3K | |
AZD8186 is an effective and specific PI3Kβ/δ inhibitor (IC50: 4/12 nM). | |||
T10804 | CHMFL-PI3KD-317 | PI3K , PI4K | |
CHMFL-PI3KD-317 is a highly potent, selective and orally active PI3Kδ inhibitor, with an IC50 of 6 nM, and exhibits over 10-1500 fold selectivity over other class I, II and III PIKK family isoforms, such as PI3Kα (IC50, ... | |||
T2365 | Pilaralisib | SAR245408,XL-147 | PI3K |
Pilaralisib (XL-147) is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K). Pilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid... | |||
T2616 | PIK-93 | PIK 93 | ATM/ATR , DNA-PK , Virus Protease , PI3K , Carbonic Anhydrase , PI4K , mTOR , HSV |
PIK-93 is the first potent, synthetic PI4K inhibitor with IC50 of 19 nM; inhibits PI3Kα with IC50 of 39 nM. | |||
T6883 | Samotolisib | GTPL8918,LY3023414 | DNA-PK , PI3K , mTOR , Autophagy |
Samotolisib (LY3023414) is an oral ATP competitive inhibitor of the class I PI3K isoforms, DNA-PK, and mTOR. Samotolisib (LY3023414) has been used in trials studying the treatment of Neoplasm, Solid Tumor, COLON CANCER, ... | |||
T25399 | ETP-45658 | ETP45658,ETP 45658 | DNA-PK , PI3K , mTOR |
ETP-45658 (ETP45658) is a PI 3-kinase inhibitor (IC50 values are 22, 30, 129 and 710 nM for PI 3-Kα, PI 3-Kδ, PI 3-Kβ and PI 3-Kγ respectively). Also inhibits DNA-PK and mTOR (IC50 values are 70.6 and 152 nM respectively... | |||
T6322 | Copanlisib | BAY 80-6946 | Apoptosis , PI3K |
Copanlisib (BAY 80-6946) is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor c... | |||
T2265 | Bimiralisib | 5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine,PQR309,PI3K-IN-2 | Others , PI3K , S6 Kinase , mTOR |
Bimiralisib (PI3K-IN-2) is an orally bioavailable pan inhibitor of PI3K and inhibitor of the mTOR, with potential antineoplastic activity. PI3K-IN-2 inhibits the PI3K kinase isoforms alpha, beta, gamma and delta and, to ... | |||
TQ0313 | NVP-BAG956 | BAG956 | PI3K |
NVP-BAG956 is an ATP-competitive PI3K inhibitor (IC50s: 34/56/112/444 nM for PI3Kδ/PI3Kα/PI3Kγ/PI3Kβ). |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T3981 | Acacetin | 4'-Methoxyapigenin,5,7-Dihydroxy-4'-methoxyflavone,Linarigenin | Apoptosis , IAP , COX , Autophagy |
Acacetin (5,7-Dihydroxy-4'-methoxyflavone) is an O-methylated flavone found in various plants, shows antinociceptive, anti-inflammatory, and antioxidant activity in various research models. | |||
T1879 | 3-Methyladenine | 3-MA,NSC 66389 | Mitophagy , PI3K , Endogenous Metabolite , Autophagy |
3-Methyladenine (3-MA) is a PI3K inhibitor that selectively inhibits class IB PI3Kγ (IC50=60 μM) and class III VPS34 (IC50=25 μM). 3-Methyladenine inhibits autophagy. | |||
T2174 | Quercetin | Sophoretin | Apoptosis , Mitophagy , Reactive Oxygen Species , PI3K , Autophagy |
Quercetin (Sophoretin) is a natural flavonoid and is an agonist of SIRT1. Quercetin is also a PI3K inhibitor, inhibiting PI3Kγ, PI3Kδ, and PI3Kβ (IC50=2.4/3.0/5.4 μM). Quercetin can induce apoptosis and autophagy. | |||
T3040 | Gallein | Pyrogallolphthalein,Mordant violet 25,Alizarin violet | Others |
Gallein (Mordant violet 25) is a small molecule inhibitor of Gβγ activity. | |||
T0579 | Myricetin | Cannabiscetin | Apoptosis , PI3K , Endogenous Metabolite , Autophagy |
Myricetin (Cannabiscetin) is a naturally-occurring flavonoid found in many grapes, berries, fruits, vegetables, herbs, as well as other plants. Walnuts are a rich dietary source. It has been shown that myricetin has anti... | |||
T6630 | Quercetin Dihydrate | Sophoretin | Apoptosis , PI3K |
Quercetin Dihydrate (Sophoretin) is a polyphenolic flavonoid that was found in a wide variety of plant-based foods, such as apples, onions, berries, and red wine. It is used for their nervous system and anticancer effect... |